E.l.f. Beauty’s profits fall 30% as China tariffs weigh on bottom line

E.l.f. Beauty’s profits fall 30% as China tariffs weigh on bottom line


E.l.f. Beauty’s profits fell 30% in its fiscal first quarter as new tariffs on Chinese imports begin to impact the cosmetic company’s bottom line.

In the three months ended June 30, E.l.f.’s net income fell to $33.3 million, down 30% from $47.6 million a year ago. The company, which sources about 75% of its products from China, also declined to provide a full-year revenue guide, citing the “wide range of potential outcomes” related to the new duties. 

Instead, the company only issued guidance for the first half of the fiscal year. E.l.f. said it’s expecting sales growth to be above 9% in the first half of the year and adjusted earnings before interest, taxes, depreciation, and amortization margins to be 20%, compared with 23% in the first half of the previous fiscal year.

“We’re operating in a very volatile macro environment, obviously a great deal of uncertainty on tariffs, so until we have greater resolution on what the tariff picture looks like, we didn’t think it made sense to issue guidance,” CEO Tarang Amin told CNBC in an interview. “It’s the uncertainty around the tariffs that make things more difficult.” 

The company has already raised prices by $1 to offset tariff costs and is working to expand its business outside of the U.S. and diversify its supply chain. 

“We’re under 55% tariffs on goods coming from China, and we’ve planned against that,” Amin said. “So I’m just waiting for that other shoe to drop to see OK, where do they really settle out? I never thought I would say a day that I’m happy to see 55% tariffs, but it’s a lot better than 170% so I think once we have that resolution, we’ll be in a better spot.”

Beyond profits, E.l.f. beat expectations on the top and bottom lines. 

Here’s how the cosmetics company performed compared with what Wall Street was anticipating, based on a survey of analysts by LSEG:

  • Earnings per share: 89 cents adjusted vs. 84 cents expected
  • Revenue: $354 million vs. $350 million expected

The company’s reported net income for the three-month period that ended June 30 was $33.3 million, or 58 cents per share, compared with $47.6 million, or 81 cents per share, a year earlier. Excluding one-time items related to stock-based compensation and other nonrecurring charges, E.l.f. saw adjusted net income of $51.3 million, or 89 cents per share.

Sales rose to $354 million, up 9% from $324 million a year earlier. That marks the second quarter in a row where revenue growth slowed to the single digits, a pattern the company hasn’t seen since 2020. 

Over the past four years, E.l.f.’s sales have consistently grown in the high double digits, but that momentum has started to slow down as the beauty category overall cools off following several years of outsized growth. 

Amin said growth is expected to improve in the current quarter. He pointed out that the quarter’s 9% sales growth is on top of 50% growth in the year-ago period but acknowledged the category at large — and the state of consumer spending — has been soft. 

“Sometimes people forget just how much we’ve been growing,” Amin said. “The category, the state of the consumer, is still challenged. There’s a lot of uncertainty with tariffs, inflation.” 

While the fiscal first quarter was slower than quarters past, Amin said Nielsen data shows the company is still taking market share and outperforming the overall category. 

A key aspect of the company’s growth comes from buzzy product launches, which are often “dupes” of higher-priced prestige products. It recently launched its Bright Icon Vitamin C + E Ferulic Serum at $17, which is thought to have been inspired by a similar product from Skinceuticals, which retails for $185.

It also released a new sunscreen and just closed on its acquisition of Hailey Bieber’s beauty brand Rhode, which will launch in all Sephora stores in the U.S. and Canada in September. The impact Rhode will have on E.l.f.’s sales, and especially its launch in Sephora, won’t be seen in its results until later this year.



Source

How Domino’s is trying to double its business during a rough patch for big pizza rivals
Business

How Domino’s is trying to double its business during a rough patch for big pizza rivals

In this photo illustration, a Domino’s pizza sits in a take-out box on July 21, 2025 in Miami, Florida. Joe Raedle | Getty Images Domino’s Pizza shares climbed on a Monday after the company posted a better-than-expected quarter and laid out ambitious growth plans. The strong performance came as the pizza chain said it saw […]

Read More
Mortgage rates just dropped below 6%, matching lowest level since 2022
Business

Mortgage rates just dropped below 6%, matching lowest level since 2022

A stock market sell-off had investors rushing to the relative safety of the bond market Monday morning, causing yields to drop and mortgage rates to follow. The average rate on the popular 30-year fixed mortgage fell to 5.99% on Monday, according to Mortgage News Daily, matching its lowest levels since 2022. Last year at this […]

Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. Cash-paying patients can […]

Read More